Wood's injury may be more serious than believed

0 Comments

Kerry Wood was scratched from his scheduled appearance Saturday with a sore right lat muscle, but the Indians quickly announced Sunday that he was already back on track and would be able to throw a bullpen session today followed by game action Wednesday.
Unfortunately, those plans have changed. Wood did not throw a bullpen session today and manager Manny Acta seemed unsure about when the Indians’ closer would be ready to pitch again:

We’re going to take it easy with Kerry. The medical staff will put together a plan for him. We want to be careful. He’s our closer. He has plenty of time to get ready, and there’s no reason to rush him back out there.

Wood’s injury was initially dismissed as merely “spring training soreness” by the Indians, but obviously there’s something else going on at this point. As beat reporter Anthony Castrovince wrote as the lead to his MLB.com story: “It could be something, it could be nothing.”
All of which is why 24-year-old setup man and potential closer-in-waiting Chris Perez is one of my fantasy “sleeper” picks for AL-only leagues.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.